Indexes MF CHC  (n=50) LF CHC  (n=55) Cirrhosis (n=9) HCC (n=3) Control group (n=25)
АSТ (u/L) 38.6 ± 6.7* 29.3 ± 8.4 40.8 ± 9.2* 43.5 ± 8.7* 19.3 ± 4.6
АLТ (u/L) 40.4 ± 8.5* 27.8 ± 7.2 39.6 ± 8.1* 37.3 ± 9.6* 22.7 ± 4.6
γ-GTP (u/L) 54.2 ± 18.3* 45.3 ± 16.7 47.5 ± 14,9* 56.3 ± 12.6* 29.4 ± 7.2
AP (u/L) 1.92 ± 0.4* 1.86 ± 0.2* 2.6 ± 1.2* 2.4 ± 0.8* 2.2 ± 1.04
Bilirubin 25.1 ± 3.77 15.5 ± 0.63 32.6 ± 2.1* 34.3 ± 1.6* 16.5 ± 2.63
Note: *differences are significant P<0.05.
Table 1: State of marker organspecific enzymes in patients with CHC depending on the form of the disease (M ± m).